Alchemab is a startup based in the United Kingdom, 1 tracked investor.
Alchemab is a startup based in the United Kingdom. Brouky records 1 investor associated with the company.
Alchemab develops AI-enabled platforms to discover and advance human-derived antibody therapies for treating diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.